Skip to main content
. 2021 Sep 15;16(1):81–88. doi: 10.1007/s12072-021-10253-z

Fig. 1.

Fig. 1

Flow chart of patient selection for the analysis. AFLD alcoholic fatty liver disease, BW body weight, FA fatty acid, NAFLD non-alcoholic fatty liver disease; US, ultrasonography